A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women

T. Cigler, H. Richardson, M. J. Yaffe, C. J. Fabian, D. Johnston, J. N. Ingle, E. Nassif, R. L. Brunner, M. E. Wood, J. L. Pater, H. Hu, S. Qi, D. Tu, P. E. Goss

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women'. Together they form a unique fingerprint.

Medicine & Life Sciences